Guanfacine Extended-Release Tablets 2 mg,100-count bottles, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-3928-1, UPC 3 60505 39281 0
Published April 14, 2021 · Recall initiated: March 31, 2021
Summary
FDA records drug Class II recall D-0324-2021, published April 14, 2021 and initiated March 31, 2021. Recalling firm: Apotex Corp.; Status: Ongoing; Reported quantity: 55620 bottles; Lot: Lot #: RX1662, RX1663, RX1664 Exp. 11/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Cross Contamination with Other Product: Product is being recalled due to Trace Amounts of Quetiapine Fumarate
What to do
Voluntary: Firm initiated · Press Release
Get an email if GUANFACINE EXTENDED-RELEASE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- GUANFACINE EXTENDED-RELEASE
- Manufacturer
- Apotex Corp.
- Distributor
- Nationwide within the United States
- UPC
- 360505392810
- Lot
- Lot #: RX1662, RX1663, RX1664 Exp. 11/2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALCL-2-0191, 5 gallon carboys, Rx only, Manufactured for: LaCore Labs, LLC, by: Washington HomeopathicApril 14, 2021
- FDAMetformin HCl Extended-Release Tablets, USP, 500 mg, Rx Only, 500-count bottle, Rx only, Distributed by: SunApril 14, 2021
- FDASp-4, 100 mL solution bottles, Rx only, Washington Homeopathic Products, Inc.260 J R Hawvermale Way BerkeleyApril 14, 2021
- FDAMometasone Furoate Topical Solution, USP, 0.1%, (Lotion), a) 30 mL (NDC 0713-0701-85) and b) 60 mL (NDCApril 14, 2021
- FDAGanirelix Acetate Injection, 250 mcg/0.5 mL, Sterile Prefilled Syringe, Rx only, Distributor: FerringApril 14, 2021
- FDANeomycin Sulfate Tablets, USP 500mg, Rx Only, 10x10 Unit dose 100 Tablets, Manufactured for: X-GENApril 14, 2021
Questions about this recall
Was Guanfacine Extended-Release Tablets 2 mg,100-count bottles, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-3928-1, UPC 3 60505 39281 0 recalled?
Yes. FDA published recall D-0324-2021 on April 14, 2021. Reported hazard: Cross Contamination with Other Product: Product is being recalled due to Trace Amounts of Quetiapine Fumarate
What should I do if I have this product?
Voluntary: Firm initiated · Press Release
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: GUANFACINE EXTENDED-RELEASE. UPC: 360505392810.